THRB and cardiac hypertrophy: Even though still at a preliminary level, ongoing studies have revealed that in F344 rats a sub-chronic treatment with the two novel TRβ-agonists, namely IS25 and TG68, induced hepatocyte proliferation in the absence of any sign of hepatic toxicity and cardiac hypertrophy (75).